Free Trial

Avalo Therapeutics (AVTX) SEC Filings & 10K Form

Avalo Therapeutics logo
$4.88 +0.01 (+0.10%)
As of 02:06 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

Recent Avalo Therapeutics SEC Filings

DateFilerForm TypeView
06/04/2025
6:01 AM
Avalo Therapeutics, Inc. (Filer)
Avalo Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/15/2025
4:33 PM
Avalo Therapeutics, Inc. (Subject)
Avalo Therapeutics (Subject)
Ikarian Capital, LLC (Filed by)
Form SCHEDULE 13G/A
05/12/2025
6:10 AM
Avalo Therapeutics, Inc. (Filer)
Avalo Therapeutics (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
05/12/2025
6:12 AM
Avalo Therapeutics, Inc. (Filer)
Avalo Therapeutics (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
05/12/2025
6:01 AM
Avalo Therapeutics, Inc. (Filer)
Avalo Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/12/2025
6:03 AM
Avalo Therapeutics, Inc. (Filer)
Avalo Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
05/08/2025
6:02 AM
Avalo Therapeutics, Inc. (Filer)
Avalo Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/01/2025
6:00 AM
Avalo Therapeutics, Inc. (Filer)
Avalo Therapeutics (Filer)
Form DEF 14A
05/01/2025
6:02 AM
Avalo Therapeutics, Inc. (Filer)
Avalo Therapeutics (Filer)
Form DEFA14A
05/01/2025
6:04 AM
Avalo Therapeutics, Inc. (Filer)
Avalo Therapeutics (Filer)
Form ARS
04/01/2025
7:06 PM
Avalo Therapeutics, Inc. (Issuer)
Avalo Therapeutics (Issuer)
Chan Mitchell (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/01/2025
3:37 PM
Avalo Therapeutics, Inc. (Issuer)
Avalo Therapeutics (Issuer)
KANTOFF AARON (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/01/2025
3:44 PM
Avalo Therapeutics, Inc. (Issuer)
Avalo Therapeutics (Issuer)
Truex Samantha (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/01/2025
3:30 PM
Avalo Therapeutics, Inc. (Issuer)
Avalo Therapeutics (Issuer)
KAPLAN GILLA (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/26/2025
6:01 AM
Avalo Therapeutics, Inc. (Filer)
Avalo Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/20/2025
6:02 AM
Avalo Therapeutics, Inc. (Filer)
Avalo Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/20/2025
6:06 AM
Avalo Therapeutics, Inc. (Filer)
Avalo Therapeutics (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
01/30/2025
4:43 PM
Avalo Therapeutics, Inc. (Issuer)
Avalo Therapeutics (Issuer)
Sullivan Christopher Ryan (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/30/2025
4:51 PM
Avalo Therapeutics, Inc. (Issuer)
Avalo Therapeutics (Issuer)
VARKI PAUL (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/30/2025
4:31 PM
Avalo Therapeutics, Inc. (Issuer)
Avalo Therapeutics (Issuer)
NEIL GARRY ARTHUR (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/30/2025
4:20 PM
Avalo Therapeutics, Inc. (Issuer)
Avalo Therapeutics (Issuer)
Doyle Mittie (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/13/2025
6:07 AM
Avalo Therapeutics, Inc. (Filer)
Avalo Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/02/2025
6:04 AM
Avalo Therapeutics, Inc. (Filer)
Avalo Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/31/2024
3:13 PM
Affinity Asset Advisors, LLC (Filed by)
Avalo Therapeutics, Inc. (Subject)
Avalo Therapeutics (Subject)
Form SCHEDULE 13G
12/05/2024
6:03 AM
Avalo Therapeutics, Inc. (Filer)
Avalo Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/14/2024
5:23 PM
Avalo Therapeutics, Inc. (Subject)
Avalo Therapeutics (Subject)
ORBIMED ADVISORS LLC (Filed by)
Form SC 13G
11/14/2024
4:21 PM
Almenoff June Sherie (Reporting)
Avalo Therapeutics, Inc. (Issuer)
Avalo Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/14/2024
11:05 AM
Allostery Investments LP (Filed by)
Avalo Therapeutics, Inc. (Subject)
Avalo Therapeutics (Subject)
Form SC 13G/A
11/12/2024
6:30 AM
Avalo Therapeutics, Inc. (Filer)
Avalo Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/07/2024
4:00 PM
Avalo Therapeutics, Inc. (Subject)
Avalo Therapeutics (Subject)
Crutcher Patrick J (Filed by)
Form SC 13G/A
11/07/2024
6:20 AM
Avalo Therapeutics, Inc. (Filer)
Avalo Therapeutics (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
11/07/2024
6:02 AM
Avalo Therapeutics, Inc. (Filer)
Avalo Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/07/2024
6:04 AM
Avalo Therapeutics, Inc. (Filer)
Avalo Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
11/07/2024
6:17 AM
Avalo Therapeutics, Inc. (Filer)
Avalo Therapeutics (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
10/08/2024
6:13 AM
Avalo Therapeutics, Inc. (Filer)
Avalo Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/07/2024
7:06 PM
Avalo Therapeutics, Inc. (Subject)
Avalo Therapeutics (Subject)
Ikarian Capital, LLC (Filed by)
Form SC 13G
09/09/2024
6:22 AM
Avalo Therapeutics, Inc. (Filer)
Avalo Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/04/2024
6:01 AM
Avalo Therapeutics, Inc. (Filer)
Avalo Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/23/2024
3:34 PM
Avalo Therapeutics, Inc. (Subject)
Avalo Therapeutics (Subject)
BIOTECHNOLOGY VALUE FUND L P (Filed by)
Form SC 13G
08/23/2024
3:16 PM
Avalo Therapeutics, Inc. (Subject)
Avalo Therapeutics (Subject)
RA CAPITAL MANAGEMENT, L.P. (Filed by)
Form SC 13G
08/14/2024
3:47 PM
Almenoff June Sherie (Reporting)
Avalo Therapeutics, Inc. (Issuer)
Avalo Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
Banks aren’t ready for this altcoin—are you? (Ad)

While everyone's distracted by Bitcoin's moves, a stealth revolution is underway. One altcoin is quietly positioning itself to overthrow the entire banking system.

Click here to access the full report now.
08/14/2024
3:36 PM
Avalo Therapeutics, Inc. (Issuer)
Avalo Therapeutics (Issuer)
KANTOFF AARON (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/14/2024
3:27 PM
Avalo Therapeutics, Inc. (Issuer)
Avalo Therapeutics (Issuer)
Truex Samantha (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/12/2024
6:01 AM
Avalo Therapeutics, Inc. (Filer)
Avalo Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/12/2024
6:03 AM
Avalo Therapeutics, Inc. (Filer)
Avalo Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
08/05/2024
11:15 PM
Avalo Therapeutics, Inc. (Filer)
Avalo Therapeutics (Filer)
Form EFFECT
07/16/2024
3:17 PM
Avalo Therapeutics, Inc. (Issuer)
Avalo Therapeutics (Issuer)
Doyle Mittie (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
07/16/2024
3:23 PM
Avalo Therapeutics, Inc. (Issuer)
Avalo Therapeutics (Issuer)
Doyle Mittie (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/16/2024
6:36 AM
Avalo Therapeutics, Inc. (Filer)
Avalo Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/11/2024
3:24 PM
Avalo Therapeutics, Inc. (Filer)
Avalo Therapeutics (Filer)
Form S-3/A
07/09/2024
6:17 AM
Avalo Therapeutics, Inc. (Filer)
Avalo Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/27/2024
6:04 AM
Avalo Therapeutics, Inc. (Filer)
Avalo Therapeutics (Filer)
Form ARS
06/27/2024
6:01 AM
Avalo Therapeutics, Inc. (Filer)
Avalo Therapeutics (Filer)
Form DEF 14A
06/27/2024
6:03 AM
Avalo Therapeutics, Inc. (Filer)
Avalo Therapeutics (Filer)
Form DEFA14A
06/24/2024
6:14 AM
Avalo Therapeutics, Inc. (Filer)
Avalo Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NASDAQ:AVTX) was last updated on 6/13/2025 by MarketBeat.com Staff
From Our Partners